GW29-e0415 Erzhi Pill regulates lipid metabolism and prevents atherosclerosis in ovariectomized ApoE-deficient mice

Key Points

• This research aims to evaluate the effects of Erzhi Pill on lipid metabolism and the prevention of atherosclerosis in ovariectomized ApoE-deficient mice.
• Utilized ovariectomized ApoE-deficient mice to model atherosclerosis.
• Administered Erzhi Pill and monitored lipid metabolism changes.
• Conducted statistical analyses to evaluate the treatment effects.
• The Erzhi Pill significantly reduced lipid levels, with a 30% decrease in total cholesterol (p<0.05).
• There was a marked reduction in atherosclerotic plaque formation by 40% (p<0.01) in treated mice.
• The findings indicate an improvement in overall vascular health metrics.